Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration entities : Abbvie inc. save search
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
Published: 2024-02-22 (Crawled : 13:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.88%
H: 1.46%
C: 1.13%
abbvie collaboration immunology
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
abbvie cell biopharma collaboration car-t
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Published: 2023-12-05 (Crawled : 15:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.51%
H: 0.68%
C: 0.32%
abbvie intelligence research collaboration
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
Published: 2023-07-26 (Crawled : 14:20) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
abbvie preclinical collaboration
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
Published: 2023-05-02 (Crawled : 11:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.1%
H: 0.96%
C: -1.26%
PSTV | $1.765 -0.57% 6.7K
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: -9.09%
pharma drug ongoing trials solutions collaboration therapeutics plus
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Published: 2023-02-23 (Crawled : 11:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.15%
H: 1.77%
C: 0.78%
abbvie collaboration genetic eye
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Published: 2023-01-10 (Crawled : 17:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
abbvie collaboration immunology biotech mrna
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Published: 2023-01-06 (Crawled : 13:20) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.83%
H: 1.98%
C: 1.04%
IMNM | $17.175 -1.18% -1.19% 850K
|
Health Technology
|
| O: 21.66%
H: 4.71%
C: -17.63%
collaboration
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
Published: 2022-12-06 (Crawled : 14:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
collaboration immunology therapeutics
Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases
Published: 2022-08-01 (Crawled : 00:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
collaboration neurological
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
collaboration disease
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
collaboration neurological therapy
Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases
Published: 2022-04-20 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
expansion research collaboration therapeutics
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.11%
H: 2.74%
C: 2.38%
covid-19 treatment research covid collaboration antiviral
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
Published: 2022-03-11 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
disease collaboration neuropsychiatric
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
Published: 2021-11-10 (Crawled : 17:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.67%
H: 1.47%
C: 1.17%
collaboration research preclinical pre-clinical
AbbVie and REGENXBIO Announce Eye Care Collaboration
Published: 2021-09-13 (Crawled : 11:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.67%
H: 1.29%
C: 0.08%
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 21.86%
H: 9.05%
C: 7.66%
CLSD | $1.32 4.76% 4.55% 330K
|
Health Technology
|
| O: 0.3%
H: 4.82%
C: 2.72%
eye collaboration
Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone
Published: 2021-08-09 (Crawled : 10:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.59%
H: 0.53%
C: -0.45%
disease alzheimer collaboration parkinson alzheimer’s milestone alzheimer's
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.0%
H: 0.43%
C: 0.14%
disease collaboration
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Published: 2021-07-08 (Crawled : 23:00) - globenewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.71%
H: 1.44%
C: 0.2%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.04%
H: 0.88%
C: 0.24%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
disease genetic collaboration rare
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.